ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.340
-0.020 (-0.85%)
At close: Nov 28, 2025, 1:00 PM EST
2.380
+0.040 (1.71%)
After-hours: Nov 28, 2025, 4:08 PM EST

ProQR Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
247273161264570211
Upgrade
Market Cap Growth
-26.48%70.19%-39.20%-53.63%170.61%-55.73%
Upgrade
Enterprise Value
14019356187430145
Upgrade
Last Close Price
2.342.651.983.708.014.20
Upgrade
PS Ratio
12.8913.5222.0556.74210.75167.33
Upgrade
PB Ratio
3.682.983.513.714.433.05
Upgrade
P/TBV Ratio
3.682.983.513.694.403.02
Upgrade
P/FCF Ratio
--7.21---
Upgrade
P/OCF Ratio
--6.75---
Upgrade
EV/Sales Ratio
7.459.557.6340.19158.93115.23
Upgrade
EV/FCF Ratio
--2.49---
Upgrade
Debt / Equity Ratio
0.290.190.480.330.530.61
Upgrade
Debt / FCF Ratio
--0.98---
Upgrade
Asset Turnover
0.140.130.040.020.020.01
Upgrade
Quick Ratio
3.303.893.517.246.837.44
Upgrade
Current Ratio
3.363.963.547.366.947.77
Upgrade
Return on Equity (ROE)
-103.76%-42.73%-51.33%-71.37%-71.62%-61.99%
Upgrade
Return on Assets (ROA)
-24.02%-12.45%-14.06%-21.38%-23.20%-29.36%
Upgrade
Return on Capital (ROIC)
-47.90%-22.82%-29.04%-31.06%-27.05%-32.03%
Upgrade
Return on Capital Employed (ROCE)
-48.70%-23.60%-33.60%-43.30%-31.40%-57.40%
Upgrade
Earnings Yield
-20.26%-10.51%-19.34%-26.05%-12.12%-27.05%
Upgrade
FCF Yield
-23.25%-14.31%13.88%-27.99%-5.29%-27.87%
Upgrade
Buyback Yield / Dilution
-27.37%-6.26%-13.08%-11.62%-28.21%-21.99%
Upgrade
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q